<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for NGSX</title>
    <link />
    <description>Headlines for NEUROGESX, INC.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>NeurogesX's CEO Discusses Q2 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/783071-neurogesx-s-ceo-discusses-q2-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 06 Aug 2012 05:55:10 GMT</pubDate>
    </item>
    <item>
      <title>Betting on the FDA: Another Round of Approval Decisions Coming for Major Drug Companies</title>
      <link>http://www.fool.com/news/xt/minyanville/www.minyanville.com/sectors/biotech-pharma/articles/map-pharmaceuticals-allergan-affymax-chelsea-therapeutics/3/9/2012/id/39823.aspx?source=itxwebtxt0000015</link>
      <author>Minyanville</author>
      <pubDate>Fri, 09 Mar 2012 10:50:00 GMT</pubDate>
    </item>
    <item>
      <title>24/7 Wall St. Closing Bell (AAPL, ARMH, QCOM, ZNGA, HALO, CWTR, FTK, HOTT, KFY, AONE, ACHN, FSYS, JK</title>
      <link>http://www.fool.com/news/xt/247wallst/247wallst.com/2012/03/08/247-wall-st-closing-bell-aapl-armh-qcom-znga-halo-cwtr-ftk-hott-kfy-aone-achn-fsys-jks-nav-ngsx-sfd-smrt-stp-vrs-stly-mwa-ssh-zltq/.aspx?source=itxwebtxt0000015</link>
      <author>247wallst</author>
      <pubDate>Thu, 08 Mar 2012 16:05:38 GMT</pubDate>
    </item>
    <item>
      <title>Second Take: Can NeurogesX Survive? (NGSX)</title>
      <link>http://www.fool.com/news/xt/247wallst/247wallst.com/2012/03/08/second-take-can-neurogesx-survive-ngsx/.aspx?source=itxwebtxt0000015</link>
      <author>247wallst</author>
      <pubDate>Thu, 08 Mar 2012 14:00:30 GMT</pubDate>
    </item>
    <item>
      <title>March Madness, Biotech Style</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/02/29/march-madness-biotech-style/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 29 Feb 2012 15:17:51 GMT</pubDate>
    </item>
    <item>
      <title>Merck, Pfizer, Bristol-Myers, Affymax, Chelsea Therapeutics Face Key Dates in March</title>
      <link>http://www.fool.com/news/xt/minyanville/www.minyanville.com/sectors/biotech-pharma/articles/merck-pfizer-bristol-myers-squibb-affymax/2/29/2012/id/39669.aspx?source=itxwebtxt0000015</link>
      <author>Minyanville</author>
      <pubDate>Wed, 29 Feb 2012 14:20:00 GMT</pubDate>
    </item>
    <item>
      <title>Merck, Affymax, Chelsea Therapeutics Face Key Dates in March</title>
      <link>http://www.fool.com/news/xt/minyanville/www.minyanville.com/sectors/biotech-pharma/articles/merck-pfizer-bristol-myers-squibb-affymax/2/29/2012/id/39669.aspx?source=itxwebtxt0000015</link>
      <author>Minyanville</author>
      <pubDate>Wed, 29 Feb 2012 14:20:00 GMT</pubDate>
    </item>
    <item>
      <title>US STOCK FUTURES: HOT STOCKS TO WATCH</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20120210-000363&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Fri, 10 Feb 2012 08:39:00 GMT</pubDate>
    </item>
    <item>
      <title>US STOCK FUTURES: HOT STOCKS TO WATCH</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20120210-000293&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Fri, 10 Feb 2012 06:33:00 GMT</pubDate>
    </item>
    <item>
      <title>Amgen, Vivus, Chelsea Therapeutics Prep for Key Catalysts in February</title>
      <link>http://www.fool.com/news/xt/minyanville/www.minyanville.com/businessmarkets/articles/amgen-vivus-chelsea-therapeutics-fda-xgeva/2/2/2012/id/39188.aspx?source=itxwebtxt0000015</link>
      <author>Minyanville</author>
      <pubDate>Thu, 02 Feb 2012 12:45:00 GMT</pubDate>
    </item>
    <item>
      <title>22 Companies With Market Cap Over $50 Million and 100%-Plus Sales Growth Forecast for 2011-12</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/255366-22-companies-with-market-cap-over-50-million-and-100-plus-sales-growth-forecast-for-2011-12.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 28 Feb 2011 10:46:30 GMT</pubDate>
    </item>
    <item>
      <title>U.S. Pharma: Latest Analyst Actions</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/240016-u-s-pharma-latest-analyst-actions.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 05 Dec 2010 03:11:42 GMT</pubDate>
    </item>
    <item>
      <title>Insiders Snapping Up Alliance Healthcare, Guaranty Bancorp and More</title>
      <link>http://www.fool.com/news/xt/bloggingstocks/www.pheedcontent.com/click.phdo.aspx?i=0d557f8fd5f4ae0f2ecb4eb2b77f93af&amp;source=itxwebtxt0000015</link>
      <author>BloggingStocks</author>
      <pubDate>Mon, 09 Aug 2010 10:40:00 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE 1-NeurogesX says shingles-pain patch available, shares up</title>
      <link>http://www.fool.com/news/xt/reuters/www.reuters.com/article/marketsnews/idussge6340i020100405.aspx?source=itxwebtxt0000015</link>
      <author>Reuters</author>
      <pubDate>Mon, 05 Apr 2010 14:42:38 GMT</pubDate>
    </item>
    <item>
      <title>US FDA approves NeurogesX Qutenza pain patch</title>
      <link>http://www.fool.com/news/xt/reuters/www.reuters.com/article/marketsNews/idUSN1652335920091116.aspx?source=itxwebtxt0000015</link>
      <author>Reuters</author>
      <pubDate>Mon, 16 Nov 2009 17:14:53 GMT</pubDate>
    </item>
  </channel>
</rss>
